Jane Ferguson PhD is an Associate Professor of Medicine in the Division of Cardiovascular Medicine and an Associate Director of the Vanderbilt Microbiome Innovation Center. Dr. Ferguson completed a BA in Human Genetics at Trinity College Dublin, and a PhD in Nutrigenomics at University College Dublin, Ireland, before moving to Philadelphia for postdoctoral training in Cardiovascular Genomics at the University of Pennsylvania. Dr. Ferguson moved to Nashville to join the faculty at Vanderbilt in October 2014.....Click the image on the left to continue reading.

Dr. Kristen Ogden and graduate student Sydni Smith build their own viruses while we asked them some questions about their research...click the image on the left to watch!

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Mackensen A, et al. in Nature Medicine, September 15, 2022 Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses. Hagan T, et al.

Dr. Wenhan Zhu and graduate student Ryan Fansler challenged each other to a pipette race while we asked them some questions about their research...click the image on the left to watch!

Lymphatic migration of unconventional T cells promotes site-specific immunity in distinct lymph nodes. Ataide M, et al. in Immunity, October 11, 2022 Gut bacterial nutrient preferences quantified in vivo. Zeng X, et al.

Professor Tim Cover and graduate student Chiamaka Okoye show off their artistic talents while we asked them some questions about their research...click the image on the left to watch!

Annet Kirabo, DVM, MSc, PhD, is an Associate Professor of Medicine in the Division of Clinical Pharmacology within the Department of Medicine at Vanderbilt University Medical Center. Dr. Kirabo is interested in understanding the role of inflammation in hypertension. She obtained her PhD from the Department of Physiology and Functional Genomics at the University of Florida College of Medicine. During her PhD training, she was awarded an American Heart Association (AHA) predoctoral fellowship to determine the specific involvement of vascular smooth muscle cell expression of Jak2 in the pathogenesis of cardiovascular disease. Ashley L. Pitzer, PhD, is a Research Instructor in the Division of Clinical Pharmacology within the Department of Medicine at Vanderbilt University Medical Center. She is interested in the molecular mechanisms and genes responsible for cardiac hypertrophy, fibrosis, and hypertension. As a PhD candidate in the Department of Pharmacology and Toxicology at the Virginia Commonwealth School of Medicine, her doctoral dissertation was a molecular study of the mechanism of RIG-I inflammasome in vascular endothelial cell dysfunction....click the image to the left to continue reading!

Dr. Tegy Vadakkan received his PhD from the University of Houston, Texas and completed postdoctoral training at Baylor College of Medicine. Before coming to Vanderbilt in January of 2022, Tegy was a lead research technologist at the Boston Children's Hospital at Harvard Medical School... Click the image on the left to continue reading.